Picture of Acotec Scientific Holdings logo

6669 Acotec Scientific Holdings Share Price

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapNeutral

Momentum

Relative Strength (%)
1m-16.25%
3m-31.7%
6m-51.46%
1yr-52.9%
Volume Change (%)
10d/3m+24.07%
Price vs... (%)
52w High-59%
50d MA-15.69%
200d MA-37.73%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)20.48
PEG Ratio (f)0.32
EPS Growth (f)174.59%
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value1.56
Price to Tang. Book1.56
Price to Free Cashflown/a
Price to Sales4.26
EV to EBITDA18.53

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital1.67%
Return on Equity1.13%
Operating Margin5.28%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total RevenueCNYm124.91193.97303.81395.55473.85567.5698.6739.56%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%n/an/an/an/a-79.31+477.98+42.86n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Acotec Scientific Holdings EPS forecast chart

Profile Summary

Acotec Scientific Holdings Ltd is a China-based interventional medical device company. The Company focuses on interventional treatment of vascular diseases, involving Drug-coated Balloons (DCB) and Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) etc. The Company has established a product portfolio for five major therapeutic areas, including vascular surgery, cardiology, nephrology, neurology and andrology. The Company's business covers China, Asia, Europe and other countries and regions.

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2023
Incorporated
December 3rd, 2020
Public Since
August 24th, 2021
No. of Employees
638
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
hk flag iconStock Exchange of Hong Kong Limited
Shares in Issue
313,389,171

6669 Share Price Performance

Upcoming Events for 6669

Acotec Scientific Holdings Ltd Annual Shareholders Meeting

Half Year 2024 Acotec Scientific Holdings Ltd Earnings Release

Similar to 6669

Picture of Beijing Airdoc Technology Co logo

Beijing Airdoc Technology Co

hk flag iconStock Exchange of Hong Kong Limited

Picture of AK Medical Holdings logo

AK Medical Holdings

hk flag iconStock Exchange of Hong Kong Limited

Picture of AMCO United Holding logo

AMCO United Holding

hk flag iconStock Exchange of Hong Kong Limited

Picture of Angelalign Technology logo

Angelalign Technology

hk flag iconStock Exchange of Hong Kong Limited

Picture of Arts Optical International Holdings logo

Arts Optical International Holdings

hk flag iconStock Exchange of Hong Kong Limited

FAQ